


Mead Johnson Nutrition Announces Closing of IPO
EVANSVILLE, Ind.--([ BUSINESS WIRE ])--Mead Johnson Nutrition Company (NYSE: MJN) today said that it has closed its previously announced initial public offering of 30 million shares of Class A common stock at the public offering price of $24 per share. Further, the underwriters of the offering have exercised their over-allotment option and purchased 4.5 million additional shares of Class A common stock.
Including the over-allotment, the Company sold 34.5 million shares in the offering for net proceeds of approximately $782 million, after deducting underwriting discounts, commissions and estimated offering expenses. The Company said that with this over-allotment, it will have 204.5 million shares of Class A and Class B common stock outstanding.
Citi, Morgan Stanley, Banc of America Securities LLC, Credit Suisse and J.P. Morgan acted as joint book-running managers for the offering. A copy of the final prospectus relating to the offering can be obtained from:
- Citigroup Global Markets Inc., Brooklyn Army Terminal, 140 58th Street, 8th Floor, Brooklyn, New York 11220, Attention: Prospectus Department, telephone (800) 831-9146, or by emailing [ batprospectusdept@citi.com ].
- Morgan Stanley & Co. Incorporated, 180 Varick Street, 2nd Floor, New York, New York 10014, Attention: Prospectus Department, telephone (866) 718-1649, or by emailing [ prospectus@morganstanley.com ].
About Mead Johnson
Mead Johnson develops, manufactures, markets and distributes more than 70 products in 50 markets worldwide primarily under the "Enfa" family of brands, including Enfamil® infant formula. For more information on Mead Johnson go to [ www.meadjohnson.com ].